You are here

Breast Clinical Research Program

The Breast Clinical Research Program is a critical component of our comprehensive approach for breast care treatment. Led by Kathy Albain, MD, professor, Loyola University Chicago Stritch School of Medicine, Department of Medicine, Division of Hematology/Oncology, our clinical researchers lead and develop major national studies that directly influence the prevention of disease, course of treatment, survival and quality of life. As a result, our team often has extensive experience with breakthrough treatments that other health systems are just beginning to offer.

Having a breast cancer research program also means we can provide patients with the option to participate in some of the world's most advanced clinical research.

Our research team is studying new breast cancer procedures that promise to dramatically reduce the amount of treatment necessary -- increasing the comfort and convenience for our patients. Thanks to the exceptional work of this nationally recognized team, we continue to lead the way in care of patients with breast cancer.